首页 | 本学科首页   官方微博 | 高级检索  
     

冠心病血小板蛋白激酶C及其抑制剂活性的变化
引用本文:葛华 李延富. 冠心病血小板蛋白激酶C及其抑制剂活性的变化[J]. 中国医科大学学报, 1999, 28(6): 447-448
作者姓名:葛华 李延富
作者单位:沈阳医学院附属中心医院循环内科(葛华),中国医科大学第一临床学院循环内科!沈阳110001(李廷富)
摘    要:目的:探讨蛋白激酶C(PKC)及蛋白激酶C抑制剂(PKCI)在冠心病发病中的作用。方法:测定42例心绞痛患者(AP)、41例急性心肌梗塞(AMI)患者、40例正常对照者(NC)血小板胞浆PKC及PKCI活性,血小板胞膜PKC活性。结果:心绞痛及急性心肌梗塞患者血小板胞浆中PKC活性显著低于正常对照组,其中心绞痛组低于急性心肌梗塞组,心绞痛及急性心肌梗塞患者血小板胞浆中PKCI活性低于正常对照组,其中心绞痛组低于急性心肌梗塞组;心绞痛及急性心肌梗塞患者血小板胞膜PKC活性显著高于正常对照组,心绞痛组高于急性心肌梗塞组。结论:PKC可能与冠心病发病有关。

关 键 词:冠心病  蛋白激酶C  蛋白激酶C抑制剂  血小板

Protein Kinase C and its Inhibitor Activity in Platelets from Patiens with Coronary Heart Disease
Ge Hua,Li Tingfu. Protein Kinase C and its Inhibitor Activity in Platelets from Patiens with Coronary Heart Disease[J]. Journal of China Medical University, 1999, 28(6): 447-448
Authors:Ge Hua  Li Tingfu
Abstract:Objective:This paper was to study the relation between protein kinase C (PKC) and protein kinase C inhibitor (PKCI) in platelets from patients with coronary heart disease.Methods:We measured the activity of PKC and PKCI in cytosol of platelet and the activity of PKC in membrane of platelet from patients with angina pectoris (AP), paients with acute myocardial infarction (AMI), and normal control persons (NC), respectively.Results:The activity of PKC and PKCI in cytosol of platelet from patients with AP and AMI were lower than those of NC, respectively; the activity of PKC in membrane of platelet from patients with AP and AMI were higher than those of NC, respectively. Conclusion:PKC and PKCI might be associated with the genesis of coronary heart disease.
Keywords:coronary heart disease  protein kinase C  protein kinase C inhibitor  platelet
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号